Skip to main content

Table 1 A list of the studies that were included in the meta-analysis and the experimental details

From: Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials

Reference

Nanomaterial/Chemical

Route of exposure

Mouse strain

Dose

Post-exposure time point

Array platform

GSE

Poulsen et al. (2015) [8]

Carbon nanotubes

Intratracheal

Adult C57BL/6

Single dose of 18, 54, 162 μg/mouse

1, 3, and 28 days

Agilent whole genome

GSE35284

Bourdon et al. (2012) [10]

Carbon black

Intratracheal

Adult C57BL/6

Single dose of 18, 54, 162 μg/mouse

1, 3, and 28 days

Agilent whole genome

GSE35193

Halappanavar et al. (2011) [13]

Nano titanium dioxide

Inhalation

Adult C57BL/6

1 h daily for 11 consecutive days to 42.4 mg

5 days

Agilent whole genome

GSE19487

Guo et al. (2012) [14]

Carbon nanotubes

Pharyngeal aspirations

Adult C57BL/6

Single dose of 0, 10, 20, 40, or 80 μg of CNT/mouse

1, 7, 28, and 56 days

Agilent whole genome

GSE29042

Reference not available

Bleomycin

Intratracheal

Adult Balb-c and C57BL6

Single dose of 0 and 1.5 U/kg body weight

24 h, 72 h, 10 day and 14 days

Affymetrix murine genome

GSE485

Erdely et al. (2012) [15]

Gas metal arc - stainless steel welding fume

Inhalation

Adult C57BL6

0 or 40 mg/m3, 3 h daily for 10 consecutive days

4 h, 14 days, 28 days

Illumina mouse bead array

GSE34056

Zeidler-Erderly et al. (2010) [16]

Gas metal arc—stainless steel welding fume

Pharyngeal aspiration

Adult A/J or C57BL/6 J

Four doses of 85 mg/kg

4 and 16 weeks

Illumina mouse bead array

GSE20174

Lewis et al. (2008) [17]

12 different lung disease model datasets including bleomycin, Th2 responses, and infection models

Differs with the model of lung disease

Differs with the model of lung disease

Differs with the model of lung disease

Differs with the model of lung disease

UCSF &Mm mouse oligo array

GSE4231

Halappanavar et al. (2015) [7]

Nano titanium dioxide

Intratracheal

Adult C57BL/6

Single dose of 18, 54, 162, or 486 μg/mouse

1 and 28 days

Agilent whole genome

GSE60801

Husain et al. (2015) [19]

Carbon Black

Intratracheal

Adult C57BL/6

Single dose of 162 μg/mouse

3 h, and 2, 3, 4, 5, 14, and 42 days

Agilent whole genome

GSE68036

Rahman et al. (manuscript in preparation)

Carbon nanotubes

Intratracheal

Adult C57BL/6

4 doses of 128 or 47.5 μg/mouse per week

60 days

Agilent whole genome

GSE65623

Thomson et al. (2012) [18]

Lung-specific TNFα over-expression

N/A

Adult C57BL/6 and transgenic mice

N/A

N/A

Agilent whole genome

GSE11037